MannKind | Laba Operasional



Operating Profit Perubahan Tanggal
Adma Biologics USD 37.08M 2.56M 2024-12
Dynavax Technologies USD -1632000 11.71M 2024-12
Eli Lilly USD 5.41B 259.6M 2025-03
Halozyme Therapeutics USD 175.5M 12.3M 2024-12
Insmed USD -230414000 16.98M 2024-12
MacroGenics USD -16587000 70.78M 2024-12
MannKind USD 13.1M 4.92M 2024-12
Merck USD 5.87B 1.57B 2025-03
Novo Nordisk DKK 33.82B 7.89B 2024-09
Pfizer USD 3.67B 4.08B 2025-03
Sanofi EUR 2.28B 1.42B 2025-03
Xencor USD 4.05M 66.33M 2024-12



MannKind Laba Operasional - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - May 2025.